Pages that link to "Q71687932"

The following pages link to The binding of human plasminogen to fibrin and fibrinogen (Q71687932):

Displaying 48 items.

• Interaction of histidine-rich glycoprotein with fibrinogen and fibrin (Q24563598) (← links)
• Subversion of host recognition and defense systems by Francisella spp (Q27025594) (← links)
• Applying results from clinical trials: tranexamic acid in trauma patients (Q28082587) (← links)
• Plasminogen on the surfaces of fibrin clots prevents adhesion of leukocytes and platelets (Q30660580) (← links)
• A novel real-time ultrasonic method for prion protein detection using plasminogen as a capture molecule (Q33292021) (← links)
• Plasmin-mediated fibrinolysis by variant recombinant tissue plasminogen activators (Q33849627) (← links)
• Fibrinolytic cross-talk: a new mechanism for plasmin formation. (Q33959551) (← links)
• Alveolar osteitis: a comprehensive review of concepts and controversies (Q34002077) (← links)
• Inner clot diffusion and permeation during fibrinolysis (Q34020283) (← links)
• Tissue plasminogen activator (tPA) inhibits plasmin degradation of fibrin. A mechanism that slows tPA-mediated fibrinolysis but does not require alpha 2-antiplasmin or leakage of intrinsic plasminogen (Q34223128) (← links)
• Rapid binding of plasminogen to streptokinase in a catalytic complex reveals a three-step mechanism (Q34283594) (← links)
• Substructure of human von Willebrand factor (Q34559664) (← links)
• Tissue-type plasminogen activator increases the binding of glu-plasminogen to clots (Q34621741) (← links)
• Endothelial cell-mediated conversion of Glu-plasminogen to Lys-plasminogen. Further evidence for assembly of the fibrinolytic system on the endothelial cell surface (Q35593586) (← links)
• Binding of Lys-plasminogen to monocytes/macrophages (Q35594485) (← links)
• Role of catalytic and lysine-binding sites in plasmin-induced neutrophil adherence to endothelium (Q35814078) (← links)
• The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type (Q36216545) (← links)
• Activity Regulation by Fibrinogen and Fibrin of Streptokinase from Streptococcus Pyogenes. (Q36261579) (← links)
• Binding of the COOH-terminal lysine residue of streptokinase to plasmin(ogen) kringles enhances formation of the streptokinase.plasmin(ogen) catalytic complexes (Q36536357) (← links)
• Plasminogen interacts with human platelets through two distinct mechanisms (Q36994814) (← links)
• Fibrinogen has chaperone-like activity (Q37144717) (← links)
• Evidence that the fibrinogen binding domain of Apo(a) is outside the lysine binding site of kringle IV-10: a study involving naturally occurring lysine binding defective lipoprotein(a) phenotypes (Q37357176) (← links)
• Binding of plasminogen activators to fibrin: characterization and pharmacological consequences (Q38687254) (← links)
• Peptides with 6-Aminohexanoic Acid: Synthesis and Evaluation as Plasmin Inhibitors (Q38704015) (← links)
• Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis (Q40512234) (← links)
• A high affinity interaction of plasminogen with fibrin is not essential for efficient activation by tissue-type plasminogen activator (Q41223914) (← links)
• Molecular and Physical Mechanisms of Fibrinolysis and Thrombolysis from Mathematical Modeling and Experiments (Q41287140) (← links)
• Distinct localizations of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cells (Q41514749) (← links)
• Evidence that the conformation of unliganded human plasminogen is maintained via an intramolecular interaction between the lysine-binding site of kringle 5 and the N-terminal peptide (Q42159197) (← links)
• Rapid-reaction kinetic characterization of the pathway of streptokinase-plasmin catalytic complex formation (Q42458195) (← links)
• Positive co-operative binding at two weak lysine-binding sites governs the Glu-plasminogen conformational change (Q42798589) (← links)
• Fibrin assembly after fibrinopeptide A release in model systems and human plasma studied with magnetic birefringence (Q42856196) (← links)
• The interaction of streptokinase.plasminogen activator complex, tissue-type plasminogen activator, urokinase and their acylated derivatives with fibrin and cyanogen bromide digest of fibrinogen. Relationship to fibrinolytic potency in vitro (Q42856990) (← links)
• Kinetic studies on the effect of heparin and fibrin on plasminogen activators (Q42857449) (← links)
• In vitro and in vivo assessment of controlled release and degradation of acoustically responsive scaffolds. (Q45207717) (← links)
• Human neutrophil elastase mediates fibrinolysis shutdown through competitive degradation of plasminogen and generation of angiostatin (Q47911192) (← links)
• Controlled release of basic fibroblast growth factor for angiogenesis using acoustically-responsive scaffolds. (Q48009478) (← links)
• Binding of latent matrix metalloproteinase 9 to fibrin: activation via a plasmin-dependent pathway (Q48033529) (← links)
• Computational Simulations of Thrombolytic Therapy in Acute Ischaemic Stroke (Q58562967) (← links)
• Analysis of ligand-binding to the kringle 4 fragment from human plasminogen (Q70182313) (← links)
• Plasminogen activation in lesional skin of Pemphigus vulgaris type Neumann (Q72076062) (← links)
• Heparin Binding Sites Are Located in a 40-kD gamma-Chain and a 36-kD beta-Chain Fragment Isolated from Human Fibrinogen (Q73286018) (← links)
• Mechanism of enhancement by fucoidan and CNBr-fibrinogen digest of the activation of glu-plasminogen by tissue plasminogen activator (Q73286195) (← links)
• Influence of Contraceptive Pill Use, Premenopause and Postmenopausal State on Hemostatic Parameters in Ethnic Chinese Women (Q73295895) (← links)
• Thrombophilia in Patients with Hypertriglyceridemia (Q73365825) (← links)
• Lactoferrin is a natural inhibitor of plasminogen activation (Q88400779) (← links)
• Tranexamic acid for post-partum haemorrhage: What, who and when (Q92293493) (← links)
• Site-specific PEGylation of micro-plasmin for improved thrombolytic therapy through engineering enhanced resistance against serpin mediated inhibition (Q92374167) (← links)